|Bid||34.89 x 1000|
|Ask||34.78 x 1000|
|Day's range||33.47 - 35.57|
|52-week range||27.38 - 165.29|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The stock market might not look so attractive right now, with the S&P 500 down 18% so far this year. Let's dig into why these three beaten-down growth stocks are good buy-and-hold investments. This virtual healthcare stock has plunged 79% from its 52-week high, but that doesn't make it a bad investment.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Jason Moser: A question I've been asking regardless of valuation with all of these businesses is, is this fundamentally a better business now than it was then?
Patients and investors flocked to Teladoc Health (NYSE: TDOC) during the early days of the pandemic. Patients did it to avoid contact with others. Investors did it to benefit from the company's incredible growth.